An Open-Label Extension of Two Phase 3 Studies Evaluating Long-Term Efficacy of FMX101 4% Minocycline Foam for the Treatment of Acne Vulgaris. J of Skin. 2019;3:S1. doi:10.25251/skin.3.supp.1